Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
about
A functional heteromeric MIF receptor formed by CD74 and CXCR4Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesisMajor histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathwayHuman leukocyte Antigen-DM polymorphisms in autoimmune diseasesAn MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient miceInsights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase HeterodimerBidirectional binding of invariant chain peptides to an MHC class II moleculeNitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell developmentDirect ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutininInfection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.Pathways of antigen processing.Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.I-Ag7 is subject to post-translational chaperoning by CLIP.Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DMDesign of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.The MHC class II cofactor HLA-DM interacts with Ig in B cells.On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.Burkitt lymphoma: pathogenesis and immune evasion.For many but not for all: how the conformational flexibility of the peptide/MHCII complex shapes epitope selectionHuman cell-based artificial antigen-presenting cells for cancer immunotherapy.Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules.Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD miceThe convergent roles of tapasin and HLA-DM in antigen presentation.Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsCell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.Direct peptide-regulatable interactions between MHC class I molecules and tapasin.The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathwayDo MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.Endogenous antigen processing drives the primary CD4+ T cell response to influenza.Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cellsMapping MHC haplotype effects in unrelated donor hematopoietic cell transplantationImmunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cellsMechanisms of peptide repertoire selection by HLA-DM
P2860
Q24322205-09CFC57E-273B-4278-9CD2-2B1B7D37A37BQ24338938-B6FE45B2-EBDA-444F-93A7-937B92474AC5Q24653956-F73ABD7A-E7C8-4150-9D05-969D8E2C7D66Q26741035-5551A9A4-0B17-404C-A438-E7B31DAA60DAQ27469164-5A2F207D-AD24-4953-8C12-20340E922BCCQ27653314-E40D57C5-4E34-41C3-9F3A-F65365BF6F66Q27666102-8E2BBC5B-FA00-4578-868B-AB4B7B1C5A06Q28505741-3393D963-9198-49B3-87A4-780332E31293Q30361736-E1D50364-042D-408D-810F-8B198EB6906DQ30376369-E21A9AE2-2D85-44EE-9116-35E615CD52ECQ30444065-9D5F65E5-52BA-4DAB-B9BC-7341737AA94EQ33619173-2C54575E-9744-4434-AD59-721472FBBD66Q33631854-82C04027-455D-4BFD-8219-6EEE8A2ED1C3Q33905228-209D69AD-9619-4AA1-8AF5-6E40B9586595Q34013568-826B5C4A-5E26-4EA7-9891-4BF3212036C7Q34083338-69C79B40-87F2-41BB-ABBD-6080B4E2B991Q34121306-2B3B7E36-F6F7-4097-ACA7-F84F6D94B7F5Q34146546-82FC57F8-BD7E-4D43-AC1B-0B62C6B71968Q34150236-70D2CBDB-7D06-4F53-89A4-5AA0D1980994Q34155809-E0F19812-6E78-439C-B633-930125DE3C7FQ34189497-09199A59-2772-4FF6-84D8-AC0F7F88FF94Q34338884-4787428C-F0C3-4CD4-A46F-EA2C3E7F4422Q34391263-CF50F3A4-F538-4F35-A3E4-50194DB900B5Q34422852-BBB42477-BC50-4D36-8074-1AE58141096EQ34460478-3F45CD5E-D4A2-4715-B815-C29FC2B1B257Q34590244-A9325848-5661-492C-BFA9-0F8D54D79B57Q34784992-26589521-6F64-45C8-A5B0-8C7FA26D90E2Q35071179-B5D429EA-5BCF-4981-A234-FB358E51346EQ35242376-A1716ED2-E0F5-4D86-8CCD-AD778E17605DQ35722245-409DABE4-DE4A-4702-AE9A-A5B92897D548Q35785432-C1D6B78C-8629-4905-A466-1A17E158FC45Q36186533-57CA4178-D4F2-46BC-B3AE-2398DFF2E9ECQ36189571-56698CCE-F26F-4276-866A-850B4D1D0EEFQ36240012-7D05EE18-D388-4C6F-A842-BBFEDC739911Q36478578-A007B9F9-AD3B-449F-AFA9-6C6D9E6ED037Q36666821-81E5D896-3B67-440A-9A08-5538C81863D7Q36837134-87280F70-B1C8-4F16-91EF-22140495AF92Q36920830-8DAEB39D-0741-4239-B064-EDB72F4512B4Q37112621-8EF4717D-3CFA-4D2E-9716-160E866C4CBFQ37228066-CAC84CFD-7D7D-476B-A283-C20C05997053
P2860
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Achieving stability through ed ...... peptide binding and expression
@ast
Achieving stability through ed ...... peptide binding and expression
@en
Achieving stability through ed ...... peptide binding and expression
@nl
type
label
Achieving stability through ed ...... peptide binding and expression
@ast
Achieving stability through ed ...... peptide binding and expression
@en
Achieving stability through ed ...... peptide binding and expression
@nl
prefLabel
Achieving stability through ed ...... peptide binding and expression
@ast
Achieving stability through ed ...... peptide binding and expression
@en
Achieving stability through ed ...... peptide binding and expression
@nl
P2093
P2860
P3181
P1476
Achieving stability through ed ...... peptide binding and expression
@en
P2093
Andrew W Lee
Cornelia H Rinderknecht
Elizabeth D Mellins
James J Harding
Robert Busch
Tara M C Hornell
Timo Burster
P2860
P304
P3181
P356
10.1111/J.0105-2896.2005.00306.X
P407
P577
2005-10-01T00:00:00Z